Bvf-Incil

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AXSM",
  "FBRX",
  "NAMS",
  "RVMD",
  "GLPG",
  "TCRX",
  "ANNX",
  "OLMA",
  "GPCR",
  "MIRM",
  "THRD",
  "TYRA",
  "KYMR",
  "GLUE",
  "ALLK",
  "AVTX",
  "EPIX",
  "OVID",
  "PVLA",
  "RPTX",
  "SABS",
  "SEPN",
  "IONS",
  null,
  "GHRS",
  "MOLN",
  "ZYME",
  "IVA",
  null,
  "RAPT",
  "PTGX",
  "FDMT",
  "TENX",
  "MLTX",
  "ACIU",
  "GLYC",
  "CDTX",
  "ELDN",
  "IMUX",
  "IKNA",
  "ITOS",
  "KURA",
  "VERV",
  "VSTM",
  "VIGL",
  "XOMA",
  "FHTX",
  "XNCR",
  "CELC",
  "CGEM",
  "CTMX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 51
Total Value: 2453567172
Accession Number: 0000921895-25-001528
Form Type: 13F-HR
CIK: bvf-incil
Manager Name: Bvf-Incil

Data Enrichment

96% identified

49 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

51 positions • $2.5B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 3

Sort by:

Septerna, Inc.

SEPN|81734D104

Shares:4.4M

Value:$25.5M

% of Portfolio:1.0% ($25.5M/$2.5B)

Eledon Pharmaceuticals, Inc.

ELDN|28617K101

Shares:6.3M

Value:$21.3M

% of Portfolio:0.9% ($21.3M/$2.5B)

Cidara Therapeutics, Inc.

CDTX|171757206

Shares:924.6K

Value:$19.9M

% of Portfolio:0.8% ($19.9M/$2.5B)

Olema Pharmaceuticals, Inc.

OLMA|68062P106

Shares:5.3M

Value:$19.9M

% of Portfolio:0.8% ($19.9M/$2.5B)

PALVELLA THERAPEUTICS, INC.

PVLA|697947109

Shares:696.6K

Value:$19.5M

% of Portfolio:0.8% ($19.5M/$2.5B)

Foghorn Therapeutics Inc.

FHTX|344174107

Shares:5.3M

Value:$19.4M

% of Portfolio:0.8% ($19.4M/$2.5B)

iTeos Therapeutics, Inc.

ITOS|46565G104

Shares:3.1M

Value:$18.4M

% of Portfolio:0.7% ($18.4M/$2.5B)

4D Molecular Therapeutics, Inc.

FDMT|35104E100

Shares:4.6M

Value:$14.7M

% of Portfolio:0.6% ($14.7M/$2.5B)

ESSA Pharma Inc.

EPIX|29668H708

Shares:8.7M

Value:$13.8M

% of Portfolio:0.6% ($13.8M/$2.5B)

Annexon, Inc.

ANNX|03589W102

Shares:7.0M

Value:$13.5M

% of Portfolio:0.6% ($13.5M/$2.5B)

Verastem, Inc.

VSTM|92337C203

Shares:2.1M

Value:$12.7M

% of Portfolio:0.5% ($12.7M/$2.5B)

RAPT Therapeutics, Inc.

RAPT|75382E109

Shares:9.2M

Value:$11.3M

% of Portfolio:0.5% ($11.3M/$2.5B)

Repare Therapeutics Inc.

RPTX|760273102

Shares:10.3M

Value:$10.2M

% of Portfolio:0.4% ($10.2M/$2.5B)

IMMUNIC, INC.

IMUX|4525EP101

Shares:8.9M

Value:$9.7M

% of Portfolio:0.4% ($9.7M/$2.5B)

Avalo Therapeutics, Inc.

AVTX|05338F306

Shares:1.0M

Value:$8.3M

% of Portfolio:0.3% ($8.3M/$2.5B)

Third Harmonic Bio, Inc.

THRD|88427A107

Shares:2.4M

Value:$8.2M

% of Portfolio:0.3% ($8.2M/$2.5B)

Vigil Neuroscience, Inc.

VIGL|92673K108

Shares:4.0M

Value:$7.1M

% of Portfolio:0.3% ($7.1M/$2.5B)

TScan Therapeutics, Inc.

TCRX|89854M101

Shares:4.9M

Value:$6.7M

% of Portfolio:0.3% ($6.7M/$2.5B)

MOLECULAR PARTNERS AG

MOLN|60853G106

Shares:1.4M

Value:$5.5M

% of Portfolio:0.2% ($5.5M/$2.5B)

Ikena Oncology, Inc.

IKNA|45175G108

Shares:4.0M

Value:$5.1M

% of Portfolio:0.2% ($5.1M/$2.5B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Septerna, Inc.(SEPNcusip81734D104)	4.4M	QoQ +79.28% (-1.9M) YoY NEW(+4.4M)	All Managers (Combined)	$25.5M	1.0% ($25.5M/$2.5B)	QoQ -54.66% (-$30.7M) YoY NEW(+$25.5M)
Eledon Pharmaceuticals, Inc.(ELDNcusip28617K101)	6.3M	QoQ 0.00% (-0) YoY +45.45% (+2.0M)	All Managers (Combined)	$21.3M	0.9% ($21.3M/$2.5B)	QoQ -17.71% (-$4.6M) YoY +139.36% (+$12.4M)
Cidara Therapeutics, Inc.(CDTXcusip171757206)	924.6K	QoQ -15.38% (-168.2K) YoY NEW(+924.6K)	All Managers (Combined)	$19.9M	0.8% ($19.9M/$2.5B)	QoQ -32.19% (-$9.5M) YoY NEW(+$19.9M)
Olema Pharmaceuticals, Inc.(OLMAcusip68062P106)	5.3M	QoQ -7.34% (-420.0K) YoY -42.03% (-3.8M)	All Managers (Combined)	$19.9M	0.8% ($19.9M/$2.5B)	QoQ -40.24% (-$13.4M) YoY -80.74% (-$83.5M)
PALVELLA THERAPEUTICS, INC.(PVLAcusip697947109)	696.6K	QoQ 0.00% (+0) YoY NEW(+696.6K)	All Managers (Combined)	$19.5M	0.8% ($19.5M/$2.5B)	QoQ +133.24% (+$11.1M) YoY NEW(+$19.5M)
Foghorn Therapeutics Inc.(FHTXcusip344174107)	5.3M	QoQ 0.00% (-0) YoY NEW(+5.3M)	All Managers (Combined)	$19.4M	0.8% ($19.4M/$2.5B)	QoQ -22.66% (-$5.7M) YoY NEW(+$19.4M)
iTeos Therapeutics, Inc.(ITOScusip46565G104)	3.1M	QoQ +32.25% (+750.0K) YoY NEW(+3.1M)	All Managers (Combined)	$18.4M	0.7% ($18.4M/$2.5B)	QoQ +2.80% (+$501.8K) YoY NEW(+$18.4M)
4D Molecular Therapeutics, Inc.(FDMTcusip35104E100)	4.6M	QoQ +70.79% (-1.9M) YoY +16.28% (-638.9K)	All Managers (Combined)	$14.7M	0.6% ($14.7M/$2.5B)	QoQ -0.95% (-$142.5K) YoY -88.21% (-$110.2M)
ESSA Pharma Inc.(EPIXcusip29668H708)	8.7M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$13.8M	0.6% ($13.8M/$2.5B)	QoQ -11.73% (-$1.8M) YoY -81.38% (-$60.5M)
Annexon, Inc.(ANNXcusip03589W102)	7.0M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$13.5M	0.6% ($13.5M/$2.5B)	QoQ -62.37% (-$22.4M) YoY -73.08% (-$36.7M)
Verastem, Inc.(VSTMcusip92337C203)	2.1M	QoQ 0.00% (+0) YoY +24.64% (-415.2K)	All Managers (Combined)	$12.7M	0.5% ($12.7M/$2.5B)	QoQ +16.63% (+$1.8M) YoY -36.30% (-$7.2M)
RAPT Therapeutics, Inc.(RAPTcusip75382E109)	9.2M	QoQ 0.00% (-0) YoY NEW(+9.2M)	All Managers (Combined)	$11.3M	0.5% ($11.3M/$2.5B)	QoQ -22.78% (-$3.3M) YoY NEW(+$11.3M)
Repare Therapeutics Inc.(RPTXcusip760273102)	10.3M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$10.2M	0.4% ($10.2M/$2.5B)	QoQ -24.74% (-$3.3M) YoY -79.06% (-$38.5M)
IMMUNIC, INC.(IMUXcusip4525EP101)	8.9M	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$9.7M	0.4% ($9.7M/$2.5B)	QoQ +8.99% (+$801.3K) YoY -17.42% (-$2.0M)
Avalo Therapeutics, Inc.(AVTXcusip05338F306)	1.0M	QoQ 0.00% (+0) YoY NEW(+1.0M)	All Managers (Combined)	$8.3M	0.3% ($8.3M/$2.5B)	QoQ +7.80% (+$601.3K) YoY NEW(+$8.3M)
Third Harmonic Bio, Inc.(THRDcusip88427A107)	2.4M	QoQ 0.00% (-0) YoY -45.64% (-2.0M)	All Managers (Combined)	$8.2M	0.3% ($8.2M/$2.5B)	QoQ -66.27% (-$16.2M) YoY -80.02% (-$33.0M)
Vigil Neuroscience, Inc.(VIGLcusip92673K108)	4.0M	QoQ +121.30% (+2.2M) YoY +121.30% (+2.2M)	All Managers (Combined)	$7.1M	0.3% ($7.1M/$2.5B)	QoQ +131.71% (+$4.1M) YoY +15.51% (+$959.8K)
TScan Therapeutics, Inc.(TCRXcusip89854M101)	4.9M	QoQ +63.55% (-1.9M) YoY +63.55% (-1.9M)	All Managers (Combined)	$6.7M	0.3% ($6.7M/$2.5B)	QoQ -25.75% (-$2.3M) YoY -71.57% (-$17.0M)
MOLECULAR PARTNERS AG(MOLNcusip60853G106)	1.4M	QoQ 0.00% (-0) YoY +205.48% (+910.7K)	All Managers (Combined)	$5.5M	0.2% ($5.5M/$2.5B)	QoQ -14.67% (-$947.8K) YoY +220.44% (+$3.8M)
Ikena Oncology, Inc.(IKNAcusip45175G108)	4.0M	QoQ 0.00% (-0) YoY -15.99% (-762.6K)	All Managers (Combined)	$5.1M	0.2% ($5.1M/$2.5B)	QoQ -21.95% (-$1.4M) YoY -24.27% (-$1.6M)